Joao P B Viola
Overview
Explore the profile of Joao P B Viola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1536
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mattos M, Sacramento C, Ferreira A, Fintelman-Rodrigues N, Pereira-Dutra F, de Freitas C, et al.
Viruses
. 2025 Jan;
16(12.
PMID: 39772165
Coronavirus disease 2019 (COVID-19) still causes death in elderly and immunocompromised individuals, for whom the sustainability of the vaccine response may be limited. Antiviral treatments, such as remdesivir or molnupiravir,...
2.
de Melo A, Lucena E, de Oliveira D, Viola J
Oncologist
. 2024 May;
29(8):e1098-e1099.
PMID: 38785402
Uveal melanoma is a rare malignancy originating from extracutaneous melanocytes on the uveal layer of the eyes. The incidence varies depending on the ethnic and racial global distribution, as uveal...
3.
Melo G, Xu T, Caloba C, Schutte A, Passos T, Neto M, et al.
J Immunol
. 2023 Jul;
211(5):721-726.
PMID: 37486206
CTL differentiation is controlled by the crosstalk of various transcription factors and epigenetic modulators. Uncovering this process is fundamental to improving immunotherapy and designing novel therapeutic approaches. In this study,...
4.
Viana M, Curty G, Furtado C, Singh B, Bendall M, Viola J, et al.
Front Microbiol
. 2023 Jan;
13:1074382.
PMID: 36713167
Due to immunosuppressive cancer therapies, cancer patients diagnosed with COVID-19 have a higher chance of developing severe symptoms and present a higher mortality rate in comparison to the general population....
5.
Souza T, Pinho V, Setim C, Sacramento C, Marcon R, Fintelman-Rodrigues N, et al.
Nat Commun
. 2023 Jan;
14(1):199.
PMID: 36639383
Orally available antivirals against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are necessary because of the continuous circulation of new variants that challenge immunized individuals. Because severe COVID-19 is a...
6.
Goes L, Siqueira J, Garrido M, Alves B, Cicala C, Arthos J, et al.
Front Microbiol
. 2022 Aug;
13:946549.
PMID: 35958144
Chronically immunosuppressed patients infected with SARS-CoV-2 often experience prolonged virus shedding, and may pave the way to the emergence of mutations that render viral variants of concern (VOC) able to...
7.
Neitzke-Montinelli V, Caloba C, Melo G, Frade B, Caramez E, Mazzoccoli L, et al.
Front Immunol
. 2022 Jun;
13:840203.
PMID: 35677061
Long-term immunological protection relies on the differentiation and maintenance of memory lymphocytes. Since the knowledge of memory generation has been centered on models of infection, there are obstacles to deep...
8.
Teixeira L, Temerozo J, Pereira-Dutra F, Ferreira A, Mattos M, Goncalves B, et al.
Front Immunol
. 2022 Mar;
13:820131.
PMID: 35251001
Coronavirus disease 2019 (COVID-19) is currently a worldwide emergency caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In observational clinical studies, statins have been identified as beneficial to hospitalized...
9.
Augusto Chaves O, Sacramento C, Ferreira A, Mattos M, Fintelman-Rodrigues N, Temerozo J, et al.
Pharmaceuticals (Basel)
. 2022 Jan;
15(1).
PMID: 35056078
Atazanavir (ATV) has already been considered as a potential repurposing drug to 2019 coronavirus disease (COVID-19); however, there are controversial reports on its mechanism of action and effectiveness as anti-severe...
10.
Goes L, Siqueira J, Garrido M, Alves B, Pereira A, Cicala C, et al.
Infect Genet Evol
. 2021 Jul;
94:104998.
PMID: 34252616
After a one-year rollout of the pandemic caused by SARS-CoV-2, the continuous dissemination of the virus has generated a number of variants with increased transmissibility and infectivity, called variants of...